Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aureos Capital was a prominent private equity firm specializing in providing venture and expansion capital to small and medium-sized enterprises (SMEs) across emerging markets. Established in 2001 as a joint venture between CDC Group and Norfund, the firm operated through an extensive network of regional offices in Asia, Africa, and Latin America. While a generalist investor, Aureos gained significant recognition in the healthcare sector by managing specialized vehicles such as the Africa Health Fund, which targeted investments in hospitals, clinics, and diagnostic centers. In 2012, the company was acquired by the Abraaj Group, integrating its operations into a larger global emerging markets platform. The firm's legacy includes pioneering institutional investment in the healthcare infrastructure of developing nations and supporting the growth of local medical service providers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aureos Capital.